Katrien Reynders-Frederix, a seasoned biotech entrepreneur with 20+ years' experience, holds a Master's in Biomedical Sciences and postgraduate studies in Business Administration. As the former CEO of Pan Cancer T, specializing in T cell therapies, she now supports early-stage biotech ventures. Passionate about translating scientific discoveries into clinical applications, Katrien is committed to driving innovation in oncology drug development.